申请人:Fujisawa Pharmaceutical Co., Ltd.
公开号:US06582351B1
公开(公告)日:2003-06-24
A compound (Ia):
wherein the variables are defined in the specification, its prodrug or a pharmaceutically acceptable salt thereof useful in the treatment of angina, hypertension etc.
一种化合物(Ia):其中变量在规范中定义,其前药或其药用可接受盐在治疗心绞痛、高血压等方面有用。